T-helper 17 cells are associated with pathology in human schistosomiasis

Journal of Infectious Diseases

Volumn 207, Issue 1, 2013, Pages 186-195

  Mbow, Moustapha ^a,b,c   Larkin, Bridget M ^d   Meurs, Lynn ^c   Wammes, Linda J ^b   De Jong, Sanne E ^b   Labuda, Lucja A ^b   Camara, Makhtar ^a   Smits, Hermelijn H ^b   Polman, Katja ^c   Dieye, Tandakha N ^a   Mboup, Souleymane ^a   Stadecker, Miguel J ^d   Yazdanbakhsh, Maria ^b  

^a University Hospital Aristide Le Dantec   (Senegal)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c Institute of Tropical Medicine of Antwerp   (Belgium)

^d TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Pathology; Schistosomiasis; Th17 cells

Indexed keywords

CD3 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 22; INTERLEUKIN 4; RETINOID RELATED ORPHAN RECEPTOR GAMMA; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR GATA 3;

ADOLESCENT; ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD; CD4+ T LYMPHOCYTE; CELL ISOLATION; CHILD; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; GRANULOCYTE; HELPER CELL; HISTOPATHOLOGY; HUMAN; HUMAN CELL; LIVER GRANULOMA; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRESCHOOL CHILD; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SCHISTOSOMA HEMATOBIUM; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; SCHISTOSOMIASIS HAEMATOBIA; SCHISTOSOMIASIS MANSONI; SCHOOL CHILD; SPLEEN; SPLEEN CELL; TH17 CELL; TH2 CELL;

ADOLESCENT; ADULT; ANIMALS; CHILD; CHILD, PRESCHOOL; CYTOKINES; FEMALE; GRANULOCYTES; HOST-PARASITE INTERACTIONS; HUMANS; INTERLEUKIN-17; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED CBA; MIDDLE AGED; SCHISTOSOMA HAEMATOBIUM; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS HAEMATOBIA; SCHISTOSOMIASIS MANSONI; SPLEEN; T-LYMPHOCYTES, REGULATORY; TH17 CELLS; URINARY BLADDER; YOUNG ADULT;

EID: 84872957710     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jis654     Document Type: Article

References (36)

1. Hotez PJ, Brindley PJ, Bethony JM, King CH, Pearce EJ, Jacobson J. Helminth infections: the great neglected tropical diseases. J Clin Invest 2008; 118:1311-21.
2. World Health Organization. Schistosomiasis fact sheet. http://www. who.int/mediacentre/factsheets/fs115/en/index.html. Accessed February 2010.
3. Gryseels B, Polman K, Clerinx J, Kestens L. Human schistosomiasis. Lancet 2006; 368:1106-18.
4. Wilson MS, Mentink-Kane MM, Pesce JT, Ramalingam TR, Thompson R, Wynn TA. Immunopathology of schistosomiasis. Immunol Cell Biol 2007; 85:148-54.
5. Wynn TA, Thompson RW, Cheever AW, Mentink-Kane MM. Immunopathogenesis of schistosomiasis. Immunol Rev 2004; 201:156-67.
6. Lehman JS Jr, Mott KE, Morrow RH Jr, Muniz TM, Boyer MH. The intensity and effects of infection with Schistosoma mansoni in a rural community in northeast Brazil. Am J Trop Med Hyg 1976; 25:285-94.
7. Caldas IR, Campi-Azevedo AC, Oliveira LF, Silveira AM, Oliveira RC, Gazzinelli G. Human schistosomiasis mansoni: immune responses during acute and chronic phases of the infection. Acta Trop 2008; 108:109-17.
8. de Jesus AR, Magalhaes A, Miranda DG, et al. Association of type 2 cytokines with hepatic fibrosis in human Schistosoma mansoni infection. Infect Immun 2004; 72:3391-7.
9. Rutitzky LI, Lopes da Rosa JR, Stadecker MJ. Severe CD4 T cell-mediated immunopathology in murine schistosomiasis is dependent on IL- 12p40 and correlates with high levels of IL-17. J Immunol 2005; 175:3920-6.
10. Fallon PG, Richardson EJ, McKenzie GJ, McKenzie AN. Schistosome infection of transgenic mice defines distinct and contrasting pathogenic roles for IL-4 and IL-13: IL-13 is a profibrotic agent. J Immunol 2000; 164:2585-91.
11. Allen JE, Wynn TA. Evolution of Th2 immunity: a rapid repair response to tissue destructive pathogens. PLoS Pathog 2011; 7: e1002003.
12. Herbert DR, Holscher C, Mohrs M, et al. Alternative macrophage activation is essential for survival during schistosomiasis and downmodulates T helper 1 responses and immunopathology. Immunity 2004; 20:623-35.
13. Rutitzky LI, Bazzone L, Shainheit MG, Joyce-Shaikh B, Cua DJ, Stadecker MJ. IL-23 is required for the development of severe egginduced immunopathology in schistosomiasis and for lesional expression of IL-17. J Immunol 2008; 180:2486-95.
14. D'Elia R, Behnke JM, Bradley JE, Else KJ. Regulatory T cells: a role in the control of helminth-driven intestinal pathology and worm survival. J Immunol 2009; 182:2340-8.
15. Wilson MS, Maizels RM. Regulatory T cells induced by parasites and the modulation of allergic responses. Chem Immunol Allergy 2006; 90:176-95.
16. Baumgart M, Tompkins F, Leng J, Hesse M. Naturally occurring CD4 +Foxp3+ regulatory T cells are an essential, IL-10-independent part of the immunoregulatory network in Schistosoma mansoni egg-induced inflammation. J Immunol 2006; 176:5374-87.
17. Hesse M, Piccirillo CA, Belkaid Y, et al. The pathogenesis of schistosomiasis is controlled by cooperating IL-10-producing innate effector and regulatory T cells. J Immunol 2004; 172:3157-66.
18. Warren KS. Schistosomiasis: host-pathogen biology. Rev Infect Dis 1982; 4:771-5.
19. Richter J, Hatz C, Campagne N, et al. Ultrasound in schistosomiasis: a practical guide to the standardized use of ultrasonography for the assessment of schistosomiasis-related morbidity. 1996; TDR/STR/SCH/ 00.1.
20. Rutitzky LI, Stadecker MJ. CD4 T cells producing pro-inflammatory interleukin-17 mediate high pathology in schistosomiasis. Mem Inst Oswaldo Cruz 2006; 101(Suppl 1):327-30.
21. Eid RE, Rao DA, Zhou J, et al. Interleukin-17 and interferon-gamma are produced concomitantly by human coronary artery-infiltrating T cells and act synergistically on vascular smooth muscle cells. Circulation 2009; 119:1424-32.
22. Rong G, Zhou Y, Xiong Y, et al. Imbalance between T helper type 17 and T regulatory cells in patients with primary biliary cirrhosis: the serum cytokine profile and peripheral cell population. Clin Exp Immunol 2009; 156:217-25.
23. Matusevicius D, Kivisakk P, He B, et al. Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis. Mult Scler 1999; 5:101-4.
24. Wong CK, Ho CY, Li EK, Lam CW. Elevation of proinflammatory cytokine (IL-18, IL-17, IL-12) and Th2 cytokine (IL-4) concentrations in patients with systemic lupus erythematosus. Lupus 2000; 9:589-93.
25. Komiyama Y, Nakae S, Matsuki T, et al. IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J Immunol 2006; 177:566-73.
26. Nakae S, Nambu A, Sudo K, Iwakura Y. Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J Immunol 2003; 171:6173-7.
27. Sakaguchi S, Setoguchi R, Yagi H, Nomura T. Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in self-tolerance and autoimmune disease. Curr Top Microbiol Immunol 2006; 305:51-66.
28. Lin MT, Storer B, Martin PJ, et al. Genetic variation in the IL-10 pathway modulates severity of acute graft-versus-host disease following hematopoietic cell transplantation: synergism between IL-10 genotype of patient and IL-10 receptor beta genotype of donor. Blood 2005; 106:3995-4001.
29. McKee AS, Pearce EJ. CD25+CD4+ cells contribute to Th2 polarization during helminth infection by suppressing Th1 response development. J Immunol 2004; 173:1224-31.
30. Herbert DR, Orekov T, Perkins C, Finkelman FD. IL-10 and TGF-beta redundantly protect against severe liver injury and mortality during acute schistosomiasis. J Immunol 2008; 181:7214-20.
31. Araujo MI, de Jesus AR, Bacellar O, Sabin E, Pearce E, Carvalho EM. Evidence of a T helper type 2 activation in human schistosomiasis. Eur J Immunol 1996; 26:1399-403.
32. Boaventura VS, Santos CS, Cardoso CR, et al. Human mucosal leishmaniasis: neutrophils infiltrate areas of tissue damage that express high levels of Th17-related cytokines. Eur J Immunol 2010; 40:2830-6.
33. Wright DG, Meierovics AI, Foxley JM. Assessing the delivery of neutrophils to tissues in neutropenia. Blood 1986; 67:1023-30.
34. Butterworth AE, Dalton PR, Dunne DW, et al. Immunity after treatment of human schistosomiasis mansoni. I. Study design, pretreatment observations and the results of treatment. Trans R Soc Trop Med Hyg 1984; 78:108-23.
35. Abath FG, Morais CN, Montenegro CE, Wynn TA, Montenegro SM. Immunopathogenic mechanisms in schistosomiasis: what can be learnt from human studies? Trends Parasitol 2006; 22:85-91.
36. Abdul-Ghani RA, Hassan AA. Murine schistosomiasis as a model for human schistosomiasis mansoni: similarities and discrepancies. Parasitol Res 2010; 107:1-8.